As the US and Europe approve plans to immunise teenagers, scientists in Britain advise delay
and Switzerland have also approved plans, while the European Medicines Agency last week agreed to extend approval for the use of the Pfizer vaccine on 12- to 15-year-olds.
Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere: